Security key
88338N107
- Security type / class
- Equity / COM
- Total 13F shares
- 164,032,510
- Total 13F value
- $1,180,505,857
- Share change
- +10,768,853
- Put/Call ratio
- 92%
- SEC-reported price per share
- $7.20
- Number of holders
- 133
- Value change
- +$86,656,418
- Number of buys
- 64
- Number of sells
- 61
Open additional details 1 more signal available
Report period
Q1 2017
Institutions
133
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N107
Recent filing periods:
Ownership snapshot
Top reported holders of TXMD - THERAPEUTICSMD INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Dec 2016
13F
Highest disclosed value: $170,141,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $170.14M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$170.14M
PRICE T ROWE ASSOCIATES INC /MD/
$136.54M
Bank of New York Mellon Corp
$121.82M
JPMORGAN CHASE & CO
$77.3M
FRANKLIN RESOURCES INC
$64.95M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
class O/S missing
|
$170,141,000
29,487,031 shares
|
— | 31 Dec 2016 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
class O/S missing
|
$136,537,000
23,663,196 shares
|
— | 31 Dec 2016 |
| Bank of New York Mellon Corp |
13F
Company
|
—
class O/S missing
|
$121,825,000
21,113,402 shares
|
— | 31 Dec 2016 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
class O/S missing
|
$77,298,000
13,396,608 shares
|
— | 31 Dec 2016 |
| FRANKLIN RESOURCES INC |
13F
Company
|
—
class O/S missing
|
$64,949,000
11,256,377 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$53,580,000
9,285,878 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
133
Shares
164,032,510
Rows available
133
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
144
Q1 2017 holders
133
Holder diff
-11
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend